Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulsatile GnRH vs sequential hCG/hMG in idiopathic hypogonadotropic hypogonadism
ChiCTR-OPC-16009168Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Mar 2014
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4 trial of gonadorelin, human chorionic gonadotropin and human menopausal gonadotrophin in Congenital Hypogonadotropic Hypogonadism (CHH) (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Proportion of patients with sperm in the ejaculate. Started Mar 2014; status: recruiting.
02
Drugs
gonadorelinhuman chorionic gonadotropinhuman menopausal gonadotrophin
03
Conditions
Congenital Hypogonadotropic Hypogonadism (CHH)
Beyond the preview
Go deeper on ChiCTR-OPC-16009168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-16009168.